Drugs, money, and secret handshakes: the unstoppable growth of prescription drug prices
In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharm...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
Cambridge University Press
2023
|
| Schlagworte: | |
| Online-Zugang: | BSB01 UBG01 Volltext |
| Zusammenfassung: | In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharmaceutical industry to expose a web of shadowy deals in which higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines. At the center of this web are the highly secretive middle players who establish coverage levels for patients and negotiate with drug companies. By offering lucrative payments to these middle players (as well as to doctors and hospitals), drug companies ensure that inexpensive drugs never gain traction. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills |
| Beschreibung: | Title from publisher's bibliographic system (viewed on 15 Dec 2023) |
| Beschreibung: | 1 Online-Ressource (xvi, 186 Seiten) |
| ISBN: | 9781009432955 |
| DOI: | 10.1017/9781009432955 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV049642661 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 240409s2023 |||| o||u| ||||||eng d | ||
| 020 | |a 9781009432955 |c Online |9 978-1-009-43295-5 | ||
| 024 | 7 | |a 10.1017/9781009432955 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9781009432955 | ||
| 035 | |a (DE-599)BVBBV049642661 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-473 | ||
| 082 | 0 | |a 338.4/76151 | |
| 100 | 1 | |a Feldman, Robin |0 (DE-588)1031349162 |4 aut | |
| 245 | 1 | 0 | |a Drugs, money, and secret handshakes |b the unstoppable growth of prescription drug prices |c Robin Feldman |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2023 | |
| 300 | |a 1 Online-Ressource (xvi, 186 Seiten) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from publisher's bibliographic system (viewed on 15 Dec 2023) | ||
| 520 | |a In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharmaceutical industry to expose a web of shadowy deals in which higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines. At the center of this web are the highly secretive middle players who establish coverage levels for patients and negotiate with drug companies. By offering lucrative payments to these middle players (as well as to doctors and hospitals), drug companies ensure that inexpensive drugs never gain traction. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills | ||
| 650 | 4 | |a Pharmaceutical industry / Economic aspects | |
| 650 | 4 | |a Drugs / Cost effectiveness | |
| 650 | 4 | |a Pharmaceutical policy | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-009-43294-8 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/9781009432955 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-20-CBO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034986263 | ||
| 966 | e | |u https://doi.org/10.1017/9781009432955 |l BSB01 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/9781009432955 |l UBG01 |p ZDB-20-CBO |q UBG_PDA_CBO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804186554158022656 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Feldman, Robin |
| author_GND | (DE-588)1031349162 |
| author_facet | Feldman, Robin |
| author_role | aut |
| author_sort | Feldman, Robin |
| author_variant | r f rf |
| building | Verbundindex |
| bvnumber | BV049642661 |
| collection | ZDB-20-CBO |
| ctrlnum | (ZDB-20-CBO)CR9781009432955 (DE-599)BVBBV049642661 |
| dewey-full | 338.4/76151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/76151 |
| dewey-search | 338.4/76151 |
| dewey-sort | 3338.4 576151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| doi_str_mv | 10.1017/9781009432955 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02483nmm a2200397zc 4500</leader><controlfield tag="001">BV049642661</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">240409s2023 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781009432955</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-009-43295-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/9781009432955</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9781009432955</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049642661</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-473</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76151</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Feldman, Robin</subfield><subfield code="0">(DE-588)1031349162</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drugs, money, and secret handshakes</subfield><subfield code="b">the unstoppable growth of prescription drug prices</subfield><subfield code="c">Robin Feldman</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvi, 186 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 15 Dec 2023)</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharmaceutical industry to expose a web of shadowy deals in which higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines. At the center of this web are the highly secretive middle players who establish coverage levels for patients and negotiate with drug companies. By offering lucrative payments to these middle players (as well as to doctors and hospitals), drug companies ensure that inexpensive drugs never gain traction. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-009-43294-8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/9781009432955</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034986263</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009432955</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009432955</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">UBG_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV049642661 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T23:39:32Z |
| indexdate | 2024-07-10T10:12:58Z |
| institution | BVB |
| isbn | 9781009432955 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034986263 |
| open_access_boolean | |
| owner | DE-12 DE-473 DE-BY-UBG |
| owner_facet | DE-12 DE-473 DE-BY-UBG |
| physical | 1 Online-Ressource (xvi, 186 Seiten) |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO UBG_PDA_CBO |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Feldman, Robin (DE-588)1031349162 aut Drugs, money, and secret handshakes the unstoppable growth of prescription drug prices Robin Feldman Cambridge Cambridge University Press 2023 1 Online-Ressource (xvi, 186 Seiten) txt rdacontent c rdamedia cr rdacarrier Title from publisher's bibliographic system (viewed on 15 Dec 2023) In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharmaceutical industry to expose a web of shadowy deals in which higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines. At the center of this web are the highly secretive middle players who establish coverage levels for patients and negotiate with drug companies. By offering lucrative payments to these middle players (as well as to doctors and hospitals), drug companies ensure that inexpensive drugs never gain traction. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills Pharmaceutical industry / Economic aspects Drugs / Cost effectiveness Pharmaceutical policy Erscheint auch als Druck-Ausgabe 978-1-009-43294-8 https://doi.org/10.1017/9781009432955 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Feldman, Robin Drugs, money, and secret handshakes the unstoppable growth of prescription drug prices Pharmaceutical industry / Economic aspects Drugs / Cost effectiveness Pharmaceutical policy |
| title | Drugs, money, and secret handshakes the unstoppable growth of prescription drug prices |
| title_auth | Drugs, money, and secret handshakes the unstoppable growth of prescription drug prices |
| title_exact_search | Drugs, money, and secret handshakes the unstoppable growth of prescription drug prices |
| title_exact_search_txtP | Drugs, money, and secret handshakes the unstoppable growth of prescription drug prices |
| title_full | Drugs, money, and secret handshakes the unstoppable growth of prescription drug prices Robin Feldman |
| title_fullStr | Drugs, money, and secret handshakes the unstoppable growth of prescription drug prices Robin Feldman |
| title_full_unstemmed | Drugs, money, and secret handshakes the unstoppable growth of prescription drug prices Robin Feldman |
| title_short | Drugs, money, and secret handshakes |
| title_sort | drugs money and secret handshakes the unstoppable growth of prescription drug prices |
| title_sub | the unstoppable growth of prescription drug prices |
| topic | Pharmaceutical industry / Economic aspects Drugs / Cost effectiveness Pharmaceutical policy |
| topic_facet | Pharmaceutical industry / Economic aspects Drugs / Cost effectiveness Pharmaceutical policy |
| url | https://doi.org/10.1017/9781009432955 |
| work_keys_str_mv | AT feldmanrobin drugsmoneyandsecrethandshakestheunstoppablegrowthofprescriptiondrugprices |